⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10421291 | 1.00 | — | — | |
| SCHEMBL14843176 | 1.00 | — | — | |
| SCHEMBL667574 | 0.83 | — | — | |
| SCHEMBL8812570 | 0.80 | LMNA (0.39) | — | |
| SCHEMBL8812227 | 0.80 | LMNA (0.39) | — | |
| SCHEMBL269374 | 0.77 | — | — | |
| SCHEMBL1934819 | 0.75 | TSHR (0.33) | — | |
| SCHEMBL9021676 | 0.73 | — | — | |
| SCHEMBL8100568 | 0.73 | — | — | |
| SCHEMBL7540941 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1749 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118159542-A | Substituted 2, 3-dihydro [1,3] thiazolo [4,5-b ] pyridines, salts thereof and their use as herbicidal agents | 拜耳公司 | 2024-06-07 | — | — | CN | claimed |
| WO-2024021261-A1 | METHOD FOR PREPARING ERIBULIN INTERMEDIATE | 上海皓元医药股份有限公司 | 2024-02-01 | — | — | WO | claimed |
| EP-4103983-B1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTER BASED C+ COMPENSATION FILMS WITH IMPROVED WAVELENGTH DISPERSION | EASTMAN CHEM CO (US) | 2024-01-24 | — | — | EP | claimed |
| CN-116693479-A | BysspinA derivative, preparation method and pharmaceutical application thereof | 中国医学科学院药物研究所 | 2023-09-05 | — | — | CN | claimed |
| WO-2023152709-A1 | RNA POLYMERASE INHIBITORS AND METHODS USING SAME | ARBUTUS BIOPHARMA CORPORATION (CA) | 2023-08-17 | — | — | WO | claimed |
| US-20230138841-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTER BASED C+ COMPENSATION FILMS WITH IMPROVED WAVELENGTH DISPERSION | EASTMAN CHEMICAL COMPANY (US) | 2023-05-04 | — | — | US | claimed |
| EP-4103983-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTER BASED C+ COMPENSATION FILMS WITH IMPROVED WAVELENGTH DISPERSION | Eastman Chemical Company (US) | 2022-12-21 | — | — | EP | claimed |
| CN-115323011-A | Preparation method of eribulin intermediate | 上海皓元医药股份有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-115087893-A | Regioselectively substituted cellulose ester based C + compensation films with improved wavelength dispersion | 伊士曼化工公司 | 2022-09-20 | — | — | CN | claimed |
| WO-2021163121-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTER BASED C+ COMPENSATION FILMS WITH IMPROVED WAVELENGTH DISPERSION | EASTMAN CHEMICAL COMPANY (US) | 2021-08-19 | — | — | WO | claimed |
| US-5270472-A | Alkanoyl L-carnitine amides with aminoacids and pharmaceutical compositions containing same for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the process of learning and memory and for the treatment of coma | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1993-12-14 | — | — | US | claimed |
| EP-0538922-A1 | Disaccharide esters of 3-methylpentanoic acid | QUEST INTERNATIONAL B.V. (NL) | 1993-04-28 | — | — | EP | claimed |
| EP-0514359-A2 | Alkanoyl L-carnitine amides with aminoacids and pharmaceutical compositions containing same, for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the processes of learning and memory, and for the treatment of coma | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-11-19 | — | — | EP | claimed |
| US-4980487-A | ANTIULCER AGENTS | KALI-CHEMIE PHARMA GMBH (DE) | 1990-12-25 | — | — | US | claimed |
| US-4911745-A | Containing a phenyl substituted in position 3 of ring | ICI AMERICAS INC. (US) | 1990-03-27 | — | — | US | claimed |
| US-4891384-A | Valepotriate hydrin containing medicines used to treat uclers and motility disturbances | KALI-CHEMIC PHARMA GMBH (DE) | 1990-01-02 | — | — | US | claimed |
| US-4829070-A | PRODRUG FOR SUSTAINED RELEASE OF DOPAMINE | UNIVERSITY OF FLORIDA (US) | 1989-05-09 | — | — | US | claimed |
| US-4727079-A | Brain-specific dopaminergic activity involving dihydropyridine carboxamides, dihydroquinoline and isoquinoline carboxamides | UNIVERSITY OF FLORIDA (US) | 1988-02-23 | — | — | US | claimed |
| EP-0133673-B1 | MEDICAMENTS CONTAINING VALEPOTRIATHYDRINES | Kali-Chemie Pharma GmbH (DE) | 1987-06-24 | — | — | EP | claimed |
| EP-0133673-A1 | Medicaments containing valepotriathydrines | Kali-Chemie Pharma GmbH (DE) | 1985-03-06 | — | — | EP | claimed |